HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC departure

This article was originally published in The Rose Sheet

Executive Summary

J. Howard Beales, III, director of the Federal Trade Commission's Bureau of Consumer Protection, will leave his post on Aug. 6 to return to academia, agency announces July 16. Beales has been director since mid-2001. Under his leadership, the agency filed 258 federal district court cases and obtained orders for about $1.3 bil. in consumer redress, FTC notes. He assisted in the creation and implementation of the National Do Not Call Registry launched late last year, and more recently urged retailers and manufacturers to consider consumer privacy concerns in implementing radio frequency identification technology (1"The Rose Sheet" June 28, 2004, p. 10). Deputy Director Lydia Parnes replaces Beales as acting director. Parnes has been with the FTC since 1981, and was appointed to her current role in 1992...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012298

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel